176 related articles for article (PubMed ID: 23750736)
1. Role of the highly conserved threonine in cytochrome P450 2E1: prevention of H2O2-induced inactivation during electron transfer.
Yoshigae Y; Kent UM; Hollenberg PF
Biochemistry; 2013 Jul; 52(27):4636-47. PubMed ID: 23750736
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
[TBL] [Abstract][Full Text] [Related]
3. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
[TBL] [Abstract][Full Text] [Related]
4. Novel reversible inactivation of cytochrome P450 2E1 T303A by tert-butyl acetylene: the role of threonine 303 in proton delivery to the active site of cytochrome P450 2E1.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
J Pharmacol Exp Ther; 2004 Jul; 310(1):281-90. PubMed ID: 14988423
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of naturally occurring isothiocyanates on the activities of cytochrome P450 2E1 and the mutant P450 2E1 T303A.
Moreno RL; Goosen T; Kent UM; Chung FL; Hollenberg PF
Arch Biochem Biophys; 2001 Jul; 391(1):99-110. PubMed ID: 11414690
[TBL] [Abstract][Full Text] [Related]
6. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation.
Lin HL; Myshkin E; Waskell L; Hollenberg PF
Chem Res Toxicol; 2007 Nov; 20(11):1612-22. PubMed ID: 17907788
[TBL] [Abstract][Full Text] [Related]
7. P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenes.
Blobaum AL; Harris DL; Hollenberg PF
Biochemistry; 2005 Mar; 44(10):3831-44. PubMed ID: 15751959
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
Moreno RL; Kent UM; Hodge K; Hollenberg PF
Chem Res Toxicol; 1999 Jul; 12(7):582-7. PubMed ID: 10409397
[TBL] [Abstract][Full Text] [Related]
9. Spectral studies of tert-butyl isothiocyanate-inactivated P450 2E1.
Kent UM; Roberts-Kirchhoff ES; Moon N; Dunham WR; Hollenberg PF
Biochemistry; 2001 Jun; 40(24):7253-61. PubMed ID: 11401573
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
Roberts ES; Alworth WL; Hollenberg PF
Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes?
Blobaum AL
Drug Metab Dispos; 2006 Jan; 34(1):1-7. PubMed ID: 16369051
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.
Zhukov A; Ingelman-Sundberg M
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489
[TBL] [Abstract][Full Text] [Related]
13. Rapid conformational dynamics of cytochrome P450 2E1 in a natural biological membrane environment.
Smith SV; Robinson RC; Smith TG; Burks SM; Friedman FK
Biochemistry; 2006 Dec; 45(51):15617-23. PubMed ID: 17176083
[TBL] [Abstract][Full Text] [Related]
14. Identification of a common cytochrome P450 epitope near the conserved heme-binding petide with antibodies raised against recombinant cytochrome P450 family 2 proteins.
Soucek P; Martin MV; Ueng YF; Guengerich FP
Biochemistry; 1995 Dec; 34(49):16013-21. PubMed ID: 8519757
[TBL] [Abstract][Full Text] [Related]
15. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
Vaz AD; Pernecky SJ; Raner GM; Coon MJ
Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
17. Heme and apoprotein modification of cytochrome P450 2B4 during its oxidative inactivation in monooxygenase reconstituted system.
Karuzina II; Zgoda VG; Kuznetsova GP; Samenkova NF; Archakov AI
Free Radic Biol Med; 1999 Mar; 26(5-6):620-32. PubMed ID: 10218650
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis at a highly conserved phenylalanine in cytochrome P450 2E1 affects heme incorporation and catalytic activity.
Porter TD
Biochemistry; 1994 May; 33(19):5942-6. PubMed ID: 8180223
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.
Fairhead M; Giannini S; Gillam EM; Gilardi G
J Biol Inorg Chem; 2005 Dec; 10(8):842-53. PubMed ID: 16283395
[TBL] [Abstract][Full Text] [Related]
20. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
